Ensysce Biosciences, Inc.
-
Ticker
ENSC
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in La Jolla, California
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses. Their approach is to look at drug delivery from a different view, using sophisticated chemistry to change the mode of activation
…More rather than just modify a formulation. They combine anti-abuse and anti-overdose technology to effectively control the way a drug is turned on or turned off. This works by means of a unique 2-step verification mechanism for oral administration.
REPORT RATINGS
4.7 / 5.0 (150)
Ensysce Biosciences, Inc. reports have an aggregate usefulness score of 4.7 based on 150 reviews.
Ensysce Biosciences, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports